🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07571694
Active, not recruiting Observational

D615L vs Zeiss 839MP: Visual Quality

NCT07571694 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai 10th People's Hospital
Phase
Observational
Started
2025-04-01
Last updated
2026-05-06

Condition(s) studied

Cataract

Investigational drug(s) / intervention(s)

Trifocal IOL

Trifocal IOL: implanted D615L

Study summary

The goal of this prospective cohort study is to compare visual quality after cataract surgery in patients implanted with a new domestic trifocal intraocular lens (D615L) versus the Zeiss AT LISA tri 839MP. The main question it aims to answer is: Is the uncorrected distance, intermediate, and near visual acuity achieved with D615L non-inferior or superior to that achieved with the Zeiss 839MP? Participants diagnosed with age-related cataract will undergo phacoemulsification and receive one of the two intraocular lenses. They will attend follow-up visits where uncorrected visual acuity, defocus curves, and the VF-14 questionnaire will be assessed over a follow-up period of at least 6 months.

Eligibility

Sex
ALL
Min age
50 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * diagnosed age-related cataract; * preoperative corneal astigmatism \<1.0 D; * endothelial cell count \>2000/mm²; * signed informed consent and ability to complete 6-month follow-up Exclusion Criteria: * prior corneal refractive, glaucoma or vitreoretinal surgery; * intraoperative posterior capsule rupture, zonular dehiscence or vitreous loss; * corneal pathology, macular edema or optic neuropathy affecting visual assessment; * active ocular inflammation, glaucoma, maculopathy or diabetic retinopathy; * uncontrolled systemic disease such as diabetes or autoimmune disorders.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Tenth People's Hospital Shanghai Shanghai Municipality

More Shanghai 10th People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07571694 on ClinicalTrials.gov ↗ ← All trials in China